{
  "schema_version": "0.1.0",
  "case_id": "HR-ML007",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "ML007",
    "display_name": "Alan Turing",
    "aliases": [
      "Alan Mathison Turing"
    ],
    "sex": "male",
    "era": "Mid-Late 20th Century",
    "nationality": "English",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1912-06-23",
          "display": "23 June 1912",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1912",
              "display": "1912",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0008"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited biographies."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "1954-06-07",
          "display": "7 June 1954",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1954",
              "display": "1954",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0008"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited biographies; he was found the next day."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-ML007-SYN",
      "ssn": "000-07-6290",
      "date_of_birth": "1985-06-23",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Rupert Hallam, MD",
      "fictional_consultant": {
        "name": "Celia Montrose-Adeyemi, MD",
        "specialty": "Endocrinology"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1912-06-23",
        "display": "23 June 1912",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born in Paddington, London.",
      "claim_ids": [
        "CLM-0001"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1951",
        "display": "1951",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Training for long-distance running around Wilmslow.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1952-03-31",
        "display": "31 March 1952",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Tried for gross indecency; accepts a year of oestrogen treatment instead of prison; loses his security clearance.",
      "claim_ids": [
        "CLM-0003",
        "CLM-0004",
        "CLM-0005",
        "CLM-0007",
        "CLM-0008"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1952-11",
        "display": "November 1952",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Decides to see a psychiatrist again and begins Jungian analysis.",
      "claim_ids": [
        "CLM-0006"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1954-06-07",
        "display": "7 June 1954",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Dies at his home in Wilmslow; the inquest verdict, suicide, is later disputed.",
      "claim_ids": [
        "CLM-0009",
        "CLM-0010",
        "CLM-0011"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "2009-09-10",
        "display": "10 September 2009",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "The Prime Minister apologises on behalf of the government.",
      "claim_ids": [
        "CLM-0012"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "2013-12-24",
        "display": "24 December 2013",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Posthumous royal pardon.",
      "claim_ids": [
        "CLM-0013"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "Alan Mathison Turing was born on 23 June 1912 in a nursing home in Paddington, London.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "Quick info and biography"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "He was a long-distance runner: he built his strength in cross-country running, was known for running to scientific meetings, and in 1951 was still training for long-distance running on the roads around Wilmslow, where he had bought his first house.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "Non-linear Life"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "After reporting a burglary at his home in 1952 he was arrested over a relationship with another man and tried on 31 March 1952 for \"gross indecency\"; rather than go to prison he accepted, for a year, oestrogen treatment intended to neutralise his libido.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Same-sex relations between men were then a crime in England; the treatment was imposed as the alternative to a prison sentence, not chosen as care.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "1952 trial"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0004",
      "statement": "His biographer Andrew Hodges writes that the drug was probably stilboestrol, a synthetic oestrogen; the 2009 government statement and other sources describe the treatment as a series of injections of female hormones.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "The exact preparation and route are not settled in the sources read.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Defiant until death"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0005",
      "statement": "Hodges describes the injurious and humiliating effect of the hormones on his body; it is often repeated that the treatment made him grow breasts, though he is known to have mentioned this only once.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "Breast growth (gynecomastia) is an expected effect of high-dose oestrogen in a man.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Defiant until death"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0006",
      "statement": "In a letter of 23 November 1952 he wrote that he had decided to have \"another, and rather more co-operative go at a psychiatrist\"; this was Jungian analysis with a refugee analyst, and he became very enthusiastic about it and wrote down all his dreams.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Seeking analysis is documented; no psychiatric diagnosis is recorded in the sources read.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Defiant until death"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0007",
      "statement": "His conviction led to the removal of his security clearance, so that he could no longer work for Government Communications Headquarters as he had since the war.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0006",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0008",
      "statement": "After the trial he returned to a wide range of academic work, including morphogenesis, quantum theory, and relativity, at Manchester University.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "1952 trial"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0009",
      "statement": "He died on 7 June 1954 at his home in Wilmslow, Cheshire, of cyanide poisoning, and the coroner's verdict was suicide.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "Quick info"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0010",
      "statement": "In 2012 Professor Jack Copeland argued that the inquest evidence would not today support a suicide verdict, that friends had described him as cheerful in the days before he died, and that accidental inhalation of cyanide from a home electrolysis experiment was equally likely.",
      "evidence_grade": "R",
      "certainty": "disputed",
      "clinical_interpretation": "A retrospective challenge to the inquest finding; the cause of death remains disputed.",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0011",
      "statement": "Hodges judges it more credible that Turing ended his own life and arranged matters so that it could be taken for an accident.",
      "evidence_grade": "R",
      "certainty": "disputed",
      "clinical_interpretation": "A biographer's interpretation; it conflicts with CLM-0010.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Defiant until death"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0012",
      "statement": "On 10 September 2009 the Prime Minister apologised on behalf of the British government, calling his treatment inhumane and describing his sentence as chemical castration by a series of injections of female hormones, accepted as the alternative to prison.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0007",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0013",
      "statement": "On 24 December 2013 he received a posthumous royal pardon; the Justice Secretary called the conviction unjust and discriminatory, and the Prime Minister said the sentence of chemical castration had caused physical and emotional damage.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0006",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0014",
      "statement": "The roster lists depression as a primary condition; the sources read document his prosecution, the hormone treatment, and his decision to seek Jungian analysis, but record no diagnosis of depression, so a depressive illness is a retrospective interpretation.",
      "evidence_grade": "R",
      "certainty": "possible",
      "clinical_interpretation": "Retrospective and uncertain; it must not be read as a documented diagnosis.",
      "source_links": [
        {
          "source_id": "SRC-0008",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Defiant until death"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Hodges A. Alan Turing (overview biography, revised from the Oxford Dictionary of National Biography entry)",
      "publisher": "Andrew Hodges, The Alan Turing Home Page",
      "url": "https://www.turing.org.uk/publications/dnb.html",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-04",
      "rights_note": "Biographer's summary on his own website; facts used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Hodges A. The Alan Turing Internet Scrapbook: Defiant until death",
      "publisher": "Andrew Hodges, The Alan Turing Home Page",
      "url": "https://www.turing.org.uk/scrapbook/wondrous.html",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-04",
      "rights_note": "Biographer's web pages quoting Turing's letters; facts used with citation."
    },
    {
      "source_id": "SRC-0003",
      "title": "O'Connor JJ, Robertson EF. Alan Mathison Turing. MacTutor History of Mathematics",
      "publisher": "University of St Andrews",
      "url": "https://mathshistory.st-andrews.ac.uk/Biographies/Turing/",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-04",
      "rights_note": "University reference biography; facts used with citation."
    },
    {
      "source_id": "SRC-0004",
      "title": "Hodges A. The Alan Turing Internet Scrapbook: Non-linear Life",
      "publisher": "Andrew Hodges, The Alan Turing Home Page",
      "url": "https://www.turing.org.uk/scrapbook/morph.html",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-04",
      "rights_note": "Biographer's web pages; facts used with citation."
    },
    {
      "source_id": "SRC-0005",
      "title": "Pease R. Alan Turing: Inquest's suicide verdict 'not supportable'. BBC News, 23 June 2012",
      "publisher": "BBC News",
      "url": "https://www.bbc.com/news/science-environment-18561092",
      "source_type": "other",
      "published": "2012-06-23",
      "accessed": "2026-11-04",
      "rights_note": "News report of Professor Copeland's argument; facts and interpretation used with citation."
    },
    {
      "source_id": "SRC-0006",
      "title": "Royal pardon for WW2 code-breaker Dr Alan Turing",
      "publisher": "UK Ministry of Justice (GOV.UK)",
      "url": "https://www.gov.uk/government/news/royal-pardon-for-ww2-code-breaker-dr-alan-turing",
      "source_type": "government",
      "published": "2013-12-24",
      "accessed": "2026-11-04",
      "rights_note": "Government press release; facts used with citation."
    },
    {
      "source_id": "SRC-0007",
      "title": "Gordon Brown issues apology for treatment of Alan Turing",
      "publisher": "The University of Manchester",
      "url": "https://www.manchester.ac.uk/about/news/gordon-brown-issues-apology-for-treatment-of-alan-turing/",
      "source_type": "other",
      "published": "2009-09-11",
      "accessed": "2026-11-04",
      "rights_note": "University news item quoting the Prime Minister's statement; facts used with citation."
    },
    {
      "source_id": "SRC-0008",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-04",
      "accessed": "2026-11-04",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-04-14",
    "index_age": 40,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Recognize and manage the harm of high-dose estrogen given to a 40-year-old gay man without his free and informed consent: evaluate gynecomastia as the EAA 2019 guideline advises (history, breast and testicular examination, testosterone, estradiol, LH, FSH, prolactin, SHBG, hCG, AFP, liver, kidney, and thyroid tests, scrotal ultrasound, breast imaging only if the examination is equivocal), name the cause as iatrogenic, stop the exposure, monitor recovery of the hypothalamic-pituitary-gonadal axis without testosterone therapy while it recovers, protect bone health, and offer surgery if gynecomastia persists; treat a moderate depressive episode with measurement-based care, gay-affirming psychotherapy, and an antidepressant only if he chooses one, with a structured suicide-risk assessment, a safety plan, and the 988 Lifeline; offer HIV and STI testing and a PrEP discussion as routine adult care with his consent; and practise LGBTQ-affirming primary care. Sexual orientation is recorded as part of his social history, never as a problem, and every test and treatment requires his free, informed consent.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-04-14",
        "purpose": "New-patient primary care visit for breast enlargement, low libido, and low mood after a year of high-dose estrogen given without his consent"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-04-28",
        "purpose": "Two-week follow-up with endocrinology consultation and scrotal ultrasound"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-06-09",
        "purpose": "Eight-week review of hormone recovery and depression treatment"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-08-04",
        "purpose": "Sixteen-week review of hormone recovery and depression treatment"
      },
      {
        "encounter_id": "ENC-006",
        "date": "2026-08-25",
        "purpose": "Same-day sick visit for a right ankle sprain"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-10-06",
        "purpose": "Six-month review of gynecomastia and depression in continuation treatment"
      },
      {
        "encounter_id": "ENC-007",
        "date": "2026-10-20",
        "purpose": "Periodic adult preventive visit"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "Bilateral gynecomastia, tender, about 4 cm of firm glandular tissue behind each nipple, after a year of high-dose estrogen; synthetic modern diagnosis linked to the documented breast growth from his hormone treatment",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "N62",
            "display": "Hypertrophy of breast",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern diagnosis. That the hormone treatment caused breast growth is reported in the sources (D, mentioned once in his own words); the examination findings are synthetic.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-002",
        "display": "Suppressed testosterone and gonadotropins from exogenous estrogen (drug-induced hypogonadotropic hypogonadism), with low libido, erectile difficulty, and fatigue",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E23.1",
            "display": "Drug-induced hypopituitarism",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic consequence of high-dose estrogen, which suppresses LH and FSH; recovery is expected once it stops.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-08-04"
      },
      {
        "id": "PRB-003",
        "display": "Adverse effects of high-dose estrogen given for a year without free and informed consent, as the alternative to imprisonment",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "T38.5X5A",
            "display": "Adverse effect of other estrogens and progestogens, initial encounter",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004",
            "CLM-0005",
            "CLM-0012",
            "CLM-0013"
          ],
          "synthetic_reason": "Synthetic modern framing of the documented hormone treatment imposed after his conviction (D); in the modern episode it is recorded as iatrogenic harm.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-004",
        "display": "Major depressive disorder, single episode, moderate, after prosecution and coerced hormone treatment; synthetic modern diagnosis (no depression diagnosis is documented in his lifetime)",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "F32.1",
            "display": "Major depressive disorder, single episode, moderate",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0014"
          ],
          "synthetic_reason": "Synthetic modern diagnosis. That he sought Jungian analysis after the trial is documented (D); calling his state then a depressive illness is a retrospective interpretation (R).",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-005",
        "display": "Vitamin D insufficiency (25-hydroxyvitamin D 22 ng/mL)",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E55.9",
            "display": "Vitamin D deficiency, unspecified",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic finding of the bone-health workup.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-10-06"
      },
      {
        "id": "PRB-006",
        "display": "Right lateral ankle sprain while trail running, able to bear weight, Ottawa ankle rules negative; resolved",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "S93.401A",
            "display": "Sprain of unspecified ligament of right ankle, initial encounter",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic sprain at an unscheduled visit, chosen to teach the Ottawa ankle rules and how to protect a depression plan that relies on running; it does not echo any documented injury.",
          "author": "The Human Record generator",
          "created": "2026-11-04T11:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-08-25",
        "abatement_date": "2026-10-20"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Cholecalciferol 1,000 units (25 mcg) oral tablet, one tablet by mouth daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "199362",
            "display": "cholecalciferol 0.025 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet by mouth daily"
        },
        "start_date": "2026-04-14",
        "indication_problem_ids": [
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vitamin D replacement for insufficiency while testosterone is low, part of the bone-health plan he agreed to.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Bupropion extended-release 150 mg oral tablet, one tablet by mouth each morning",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "993541",
            "display": "24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet by mouth each morning"
        },
        "start_date": "2026-06-09",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic antidepressant he chose at eight weeks, after an informed discussion, for a partial response to psychotherapy alone; chosen for its low rate of sexual side effects and no weight gain.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Ibuprofen 400 mg oral tablet, one tablet by mouth up to three times a day with food for no more than 5 days",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "197805",
            "display": "ibuprofen 400 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 8,
          "period_unit": "h",
          "text": "One tablet up to three times a day with food, for no more than 5 days"
        },
        "start_date": "2026-08-25",
        "end_date": "2026-08-30",
        "indication_problem_ids": [
          "PRB-006"
        ],
        "as_needed": true,
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic short NSAID course for pain from an acute ankle sprain; no interaction with bupropion or cholecalciferol.",
          "author": "The Human Record generator",
          "created": "2026-11-04T11:00:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-PHQ9-V1",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-04-14",
        "value": 15,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0014"
          ],
          "synthetic_reason": "Synthetic moderate depressive symptoms after prosecution and coerced hormone treatment; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-GAD7-V1",
        "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
        "label": "GAD-7",
        "status": "final",
        "effective_date": "2026-04-14",
        "value": 8,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "70274-6",
            "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mild anxiety symptoms.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V1",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-04-14",
        "value": 2,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic alcohol screen below the threshold for men.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-TESTO-V1",
        "display": "Testosterone [Mass/volume] in Serum or Plasma",
        "label": "Total testosterone",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-14",
        "value": 112,
        "unit": "ng/dL",
        "reference_range": {
          "low": 264,
          "high": 916
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2986-8",
            "display": "Testosterone [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004",
            "CLM-0005",
            "CLM-0012",
            "CLM-0013"
          ],
          "synthetic_reason": "Synthetic gynecomastia workup three weeks after the last high-dose estrogen injection (EAA 2019): suppressed gonadotropins and testosterone with a raised estradiol, as exogenous estrogen predicts.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-E2-V1",
        "display": "Estradiol (E2) [Mass/volume] in Serum or Plasma",
        "label": "Estradiol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-14",
        "value": 148,
        "unit": "pg/mL",
        "reference_range": {
          "low": 7.6,
          "high": 42.6
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2243-4",
            "display": "Estradiol (E2) [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004",
            "CLM-0005",
            "CLM-0012",
            "CLM-0013"
          ],
          "synthetic_reason": "Synthetic gynecomastia workup three weeks after the last high-dose estrogen injection (EAA 2019): suppressed gonadotropins and testosterone with a raised estradiol, as exogenous estrogen predicts.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-LH-V1",
        "display": "Lutropin [Units/volume] in Serum or Plasma",
        "label": "LH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-14",
        "value": 0.3,
        "unit": "m[IU]/mL",
        "reference_range": {
          "low": 1.7,
          "high": 8.6
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "10501-5",
            "display": "Lutropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004",
            "CLM-0005",
            "CLM-0012",
            "CLM-0013"
          ],
          "synthetic_reason": "Synthetic gynecomastia workup three weeks after the last high-dose estrogen injection (EAA 2019): suppressed gonadotropins and testosterone with a raised estradiol, as exogenous estrogen predicts.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-FSH-V1",
        "display": "Follitropin [Units/volume] in Serum or Plasma",
        "label": "FSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-14",
        "value": 0.4,
        "unit": "m[IU]/mL",
        "reference_range": {
          "low": 1.5,
          "high": 12.4
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "15067-2",
            "display": "Follitropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004",
            "CLM-0005",
            "CLM-0012",
            "CLM-0013"
          ],
          "synthetic_reason": "Synthetic gynecomastia workup three weeks after the last high-dose estrogen injection (EAA 2019): suppressed gonadotropins and testosterone with a raised estradiol, as exogenous estrogen predicts.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-SHBG-V1",
        "display": "Sex hormone binding globulin [Moles/volume] in Serum or Plasma",
        "label": "SHBG",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-14",
        "value": 88,
        "unit": "nmol/L",
        "reference_range": {
          "low": 16.5,
          "high": 55.9
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13967-5",
            "display": "Sex hormone binding globulin [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004",
            "CLM-0005",
            "CLM-0012",
            "CLM-0013"
          ],
          "synthetic_reason": "Synthetic gynecomastia workup three weeks after the last high-dose estrogen injection (EAA 2019): suppressed gonadotropins and testosterone with a raised estradiol, as exogenous estrogen predicts.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-PRL-V1",
        "display": "Prolactin [Mass/volume] in Serum or Plasma",
        "label": "Prolactin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-14",
        "value": 21.6,
        "unit": "ng/mL",
        "reference_range": {
          "low": 4.0,
          "high": 15.2
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2842-3",
            "display": "Prolactin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mild prolactin rise, an expected effect of high-dose estrogen; to be repeated after the estrogen clears.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-HCG-V1",
        "display": "Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma",
        "label": "hCG (beta subunit)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-14",
        "value": 1,
        "unit": "m[IU]/mL",
        "reference_range": {
          "high": 3
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "21198-7",
            "display": "Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hCG below the detection threshold; no evidence of an hCG-secreting tumor.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-AFP-V1",
        "display": "Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma",
        "label": "AFP",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-14",
        "value": 2.6,
        "unit": "ng/mL",
        "reference_range": {
          "high": 8.3
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1834-1",
            "display": "Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal AFP; no evidence of a germ cell tumor.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V1",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-14",
        "value": 22,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 55
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal liver tests; liver disease excluded as a cause of gynecomastia.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V1",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-14",
        "value": 24,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 48
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal liver tests; liver disease excluded as a cause of gynecomastia.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V1",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-14",
        "value": 0.6,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal liver tests; liver disease excluded as a cause of gynecomastia.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-14",
        "value": 0.96,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal kidney function; kidney disease excluded as a cause of gynecomastia.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-14",
        "value": 102,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic eGFR from the CKD-EPI 2021 equation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V1",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-14",
        "value": 1.9,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.4,
          "high": 4.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal TSH; hyperthyroidism excluded as a cause of gynecomastia and hypothyroidism as a cause of low mood.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-14",
        "value": 13.0,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.2,
          "high": 16.6
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mildly low hemoglobin, expected with low testosterone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-VITD-V1",
        "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
        "label": "25-hydroxyvitamin D",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-14",
        "value": 22,
        "unit": "ng/mL",
        "reference_range": {
          "low": 30,
          "high": 100
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "62292-8",
            "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vitamin D insufficiency, checked as part of bone health while testosterone is low.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V2",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-04-28",
        "value": 14,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9 after two weeks of psychotherapy; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-E2-V2",
        "display": "Estradiol (E2) [Mass/volume] in Serum or Plasma",
        "label": "Estradiol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-28",
        "value": 46,
        "unit": "pg/mL",
        "reference_range": {
          "low": 7.6,
          "high": 42.6
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2243-4",
            "display": "Estradiol (E2) [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic estradiol falling as the injected estrogen clears.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-LH-V2",
        "display": "Lutropin [Units/volume] in Serum or Plasma",
        "label": "LH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-28",
        "value": 0.9,
        "unit": "m[IU]/mL",
        "reference_range": {
          "low": 1.7,
          "high": 8.6
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "10501-5",
            "display": "Lutropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic LH still suppressed five weeks after the last injection.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V3",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-06-09",
        "value": 12,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic partial response to psychotherapy alone after eight weeks; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-GAD7-V3",
        "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
        "label": "GAD-7",
        "status": "final",
        "effective_date": "2026-06-09",
        "value": 6,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "70274-6",
            "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic improving anxiety symptoms.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-TESTO-V3",
        "display": "Testosterone [Mass/volume] in Serum or Plasma",
        "label": "Total testosterone",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-09",
        "value": 238,
        "unit": "ng/dL",
        "reference_range": {
          "low": 264,
          "high": 916
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2986-8",
            "display": "Testosterone [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic recovery of the hypothalamic-pituitary-gonadal axis about eleven weeks after the last estrogen injection.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-E2-V3",
        "display": "Estradiol (E2) [Mass/volume] in Serum or Plasma",
        "label": "Estradiol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-09",
        "value": 26,
        "unit": "pg/mL",
        "reference_range": {
          "low": 7.6,
          "high": 42.6
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2243-4",
            "display": "Estradiol (E2) [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic recovery of the hypothalamic-pituitary-gonadal axis about eleven weeks after the last estrogen injection.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-LH-V3",
        "display": "Lutropin [Units/volume] in Serum or Plasma",
        "label": "LH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-09",
        "value": 2.4,
        "unit": "m[IU]/mL",
        "reference_range": {
          "low": 1.7,
          "high": 8.6
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "10501-5",
            "display": "Lutropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic recovery of the hypothalamic-pituitary-gonadal axis about eleven weeks after the last estrogen injection.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-FSH-V3",
        "display": "Follitropin [Units/volume] in Serum or Plasma",
        "label": "FSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-09",
        "value": 3.1,
        "unit": "m[IU]/mL",
        "reference_range": {
          "low": 1.5,
          "high": 12.4
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "15067-2",
            "display": "Follitropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic recovery of the hypothalamic-pituitary-gonadal axis about eleven weeks after the last estrogen injection.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-PRL-V3",
        "display": "Prolactin [Mass/volume] in Serum or Plasma",
        "label": "Prolactin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-09",
        "value": 12.4,
        "unit": "ng/mL",
        "reference_range": {
          "low": 4.0,
          "high": 15.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2842-3",
            "display": "Prolactin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic prolactin back in range once the estrogen cleared.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V3",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-09",
        "value": 13.6,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.2,
          "high": 16.6
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hemoglobin back in range as testosterone recovers.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V4",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-08-04",
        "value": 7,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic response (53 percent reduction) eight weeks after adding bupropion to psychotherapy; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-TESTO-V4",
        "display": "Testosterone [Mass/volume] in Serum or Plasma",
        "label": "Total testosterone",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 452,
        "unit": "ng/dL",
        "reference_range": {
          "low": 264,
          "high": 916
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2986-8",
            "display": "Testosterone [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic full recovery of the gonadal axis about four months after the last estrogen injection.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-LH-V4",
        "display": "Lutropin [Units/volume] in Serum or Plasma",
        "label": "LH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 4.8,
        "unit": "m[IU]/mL",
        "reference_range": {
          "low": 1.7,
          "high": 8.6
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "10501-5",
            "display": "Lutropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic full recovery of the gonadal axis about four months after the last estrogen injection.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-FSH-V4",
        "display": "Follitropin [Units/volume] in Serum or Plasma",
        "label": "FSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 5.2,
        "unit": "m[IU]/mL",
        "reference_range": {
          "low": 1.5,
          "high": 12.4
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "15067-2",
            "display": "Follitropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic full recovery of the gonadal axis about four months after the last estrogen injection.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V4",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-04",
        "value": 14.4,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.2,
          "high": 16.6
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal hemoglobin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V5",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-10-06",
        "value": 4,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic remission (PHQ-9 4); item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-GAD7-V5",
        "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
        "label": "GAD-7",
        "status": "final",
        "effective_date": "2026-10-06",
        "value": 3,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "70274-6",
            "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic minimal anxiety symptoms.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-TESTO-V5",
        "display": "Testosterone [Mass/volume] in Serum or Plasma",
        "label": "Total testosterone",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-06",
        "value": 536,
        "unit": "ng/dL",
        "reference_range": {
          "low": 264,
          "high": 916
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2986-8",
            "display": "Testosterone [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal testosterone six months after the estrogen stopped.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-E2-V5",
        "display": "Estradiol (E2) [Mass/volume] in Serum or Plasma",
        "label": "Estradiol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-06",
        "value": 24,
        "unit": "pg/mL",
        "reference_range": {
          "low": 7.6,
          "high": 42.6
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2243-4",
            "display": "Estradiol (E2) [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal estradiol.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-VITD-V5",
        "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
        "label": "25-hydroxyvitamin D",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-06",
        "value": 38,
        "unit": "ng/mL",
        "reference_range": {
          "low": 30,
          "high": 100
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "62292-8",
            "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vitamin D repleted on cholecalciferol.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-PREV",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-10-20",
        "value": 3,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic continuation-phase PHQ-9 in remission; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T11:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-PREV",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-10-20",
        "value": 2,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic alcohol screen below the threshold.",
          "author": "The Human Record generator",
          "created": "2026-11-04T11:00:00-05:00"
        }
      },
      {
        "id": "OBS-CHOL-PREV",
        "display": "Cholesterol [Mass/volume] in Serum or Plasma",
        "label": "Total cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-20",
        "value": 182,
        "unit": "mg/dL",
        "reference_range": {
          "high": 199
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2093-3",
            "display": "Cholesterol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic cardiovascular risk screening at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T11:00:00-05:00"
        }
      },
      {
        "id": "OBS-HDL-PREV",
        "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "label": "HDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-20",
        "value": 62,
        "unit": "mg/dL",
        "reference_range": {
          "low": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic cardiovascular risk screening at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T11:00:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-PREV",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-20",
        "value": 104,
        "unit": "mg/dL",
        "reference_range": {
          "high": 129
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic cardiovascular risk screening at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T11:00:00-05:00"
        }
      },
      {
        "id": "OBS-TG-PREV",
        "display": "Triglyceride [Mass/volume] in Serum or Plasma",
        "label": "Triglycerides",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-20",
        "value": 80,
        "unit": "mg/dL",
        "reference_range": {
          "high": 149
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2571-8",
            "display": "Triglyceride [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic cardiovascular risk screening at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T11:00:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "Scrotal ultrasound for gynecomastia workup: testes about 15 mL each, homogeneous, no mass; no varicocele",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "1220587009",
            "display": "Ultrasonography of scrotum",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-04-28",
          "end": "2026-04-28"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic scrotal ultrasound advised by the EAA guideline in the gynecomastia workup; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T11:30:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "Advance care planning conversation, about 20 minutes",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "713603004",
            "display": "Advance care planning",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-10-20",
          "end": "2026-10-20"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic voluntary advance care planning at the preventive visit; names no real person.",
          "author": "The Human Record generator",
          "created": "2026-11-04T11:00:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "Influenza vaccine, 2025-2026 season",
        "status": "completed",
        "date": "2025-10-14",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic adult immunization history in the modern frame; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "Tdap vaccine",
        "status": "completed",
        "date": "2021-05-11",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "115",
            "display": "Tdap",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic adult immunization history in the modern frame; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Influenza vaccine, 2026-2027 season",
        "status": "completed",
        "date": "2026-10-20",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic yearly influenza vaccination, given with his consent.",
          "author": "The Human Record generator",
          "created": "2026-11-04T11:00:00-05:00"
        }
      }
    ],
    "family_history": [],
    "past_medical_history": [
      {
        "id": "PMH-001",
        "display": "Year of oestrogen treatment (probably stilboestrol) accepted as the alternative to prison after his conviction for gross indecency",
        "historical_date": {
          "iso": "1952-03-31",
          "display": "31 March 1952",
          "precision": "day",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "PMH-002",
        "display": "Breast growth attributed to the hormone treatment, which he is known to have mentioned once",
        "historical_date": {
          "iso": "1952",
          "display": "1952",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "PMH-003",
        "display": "Decided to see a psychiatrist again and began Jungian analysis",
        "historical_date": {
          "iso": "1952-11",
          "display": "November 1952",
          "precision": "month",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      }
    ],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "New-patient primary care visit for breast enlargement, low libido, and low mood after a year of high-dose estrogen given without his consent",
        "status": "finished",
        "date": "2026-04-14",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "Two-week follow-up with endocrinology consultation and scrotal ultrasound",
        "status": "finished",
        "date": "2026-04-28",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Two-week follow-up; endocrinology consultation and scrotal ultrasound today",
          "hpi": {
            "narrative": "Mr. Turing returns two weeks after his first visit, five weeks after the last estrogen injection. He saw Dr. Montrose-Adeyemi of endocrinology this morning and had a scrotal ultrasound, which was normal. His breasts are still tender against his shirt, with no change in size, and he has had no nipple discharge. Libido and morning erections are still absent. He has had two sessions with the clinic psychologist and found them easier than he expected; they have begun with what was done to him rather than with his sexuality, which he says he has never regarded as the problem. He sleeps five to six hours and has run twice this week, alone. He has had no suicidal thoughts and keeps his safety plan on his phone. He takes cholecalciferol daily.",
            "elements": [
              {
                "label": "Breasts",
                "value": "Still tender; no change in size; no discharge"
              },
              {
                "label": "Sexual function",
                "value": "Libido and morning erections still absent"
              },
              {
                "label": "Psychotherapy",
                "value": "Two sessions with the clinic psychologist"
              },
              {
                "label": "Sleep and activity",
                "value": "Five to six hours; ran twice this week"
              },
              {
                "label": "Safety",
                "value": "No suicidal thoughts since intake; safety plan on his phone"
              },
              {
                "label": "PHQ-9",
                "value": "14, down from 15"
              }
            ]
          },
          "ros": [
            {
              "system": "Breast",
              "status": "positive",
              "finding": "Tender breast tissue on both sides; no discharge or new lump"
            },
            {
              "system": "Genitourinary",
              "status": "positive",
              "finding": "Low libido and no morning erections; no testicular pain or swelling"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No leg swelling or calf pain"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Low mood and interest, poor sleep; no suicidal thoughts, elevated mood, or racing thoughts"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Tall, lean, tired"
            },
            {
              "system": "Breast",
              "finding": "Examined with his agreement and a chaperone offered and declined: firm, tender, rubbery disc of glandular tissue about 4 cm across behind each nipple, centered and symmetric; no discrete or eccentric mass, skin change, nipple discharge, or axillary nodes"
            },
            {
              "system": "Genitourinary",
              "finding": "Examined with his agreement: testes soft and slightly small, without masses, as the ultrasound confirmed"
            },
            {
              "system": "Mental status",
              "finding": "Alert and cooperative; mood \"still flat\"; affect constricted but brightens on his work; thought process linear; no suicidal ideation; no psychotic features; insight and judgment good"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "Bilateral gynecomastia from exogenous estrogen",
              "assessment": "Typical bilateral gynecomastia on examination, so breast imaging is not needed. Endocrinology agrees that the estrogen explains it: hCG and AFP are normal and the scrotal ultrasound shows no mass. Estradiol is falling (46 pg/mL)",
              "plan": [
                "Watchful waiting; no tamoxifen or other drug, as Dr. Montrose-Adeyemi advised",
                "A compression shirt for running if he wishes"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Drug-induced hypogonadotropic hypogonadism",
              "assessment": "LH still suppressed at 0.9 mIU/mL five weeks after the last injection; recovery is expected over two to six months",
              "plan": [
                "No testosterone therapy while the axis recovers",
                "Testosterone, estradiol, LH, FSH, prolactin, and hemoglobin in six weeks"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Major depressive disorder, single episode, moderate",
              "assessment": "PHQ-9 14, down from 15, two weeks into psychotherapy. No past mania or hypomania. Suicide risk remains low, with no ideation since intake and protective factors unchanged",
              "plan": [
                "Continue weekly psychotherapy; review the antidepressant question at eight weeks if the PHQ-9 has not fallen by half",
                "Collaborative safety plan reviewed and unchanged; 988 Suicide & Crisis Lifeline and the clinic number confirmed"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Breast examination for size, tenderness, and any discrete mass",
              "cadence": "Every visit until the gynecomastia settles",
              "status": "completed_today",
              "detail": "Firm, tender glandular tissue about 4 cm behind each nipple; symmetric; no discrete mass, skin change, discharge, or nodes",
              "guideline_ids": [
                "GL-EAA-GM-2019",
                "GL-ES-HYPOGONAD-2018"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Breast ultrasound or mammography",
              "cadence": "Only if the examination is equivocal or a discrete mass is felt",
              "status": "not_indicated",
              "detail": "Typical bilateral, centered gynecomastia on examination",
              "guideline_ids": [
                "GL-EAA-GM-2019",
                "GL-ES-HYPOGONAD-2018"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Scrotal ultrasound",
              "cadence": "Once, in the gynecomastia workup",
              "status": "completed_today",
              "detail": "Testes about 15 mL each, homogeneous; no mass; no varicocele",
              "guideline_ids": [
                "GL-EAA-GM-2019",
                "GL-ES-HYPOGONAD-2018"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Estradiol and LH while the estrogen clears",
              "cadence": "Every 6 to 8 weeks after the exposure stops, until normal",
              "status": "completed_today",
              "detail": "Estradiol 46 pg/mL, down from 148; LH 0.9 mIU/mL, still suppressed",
              "observation_ids": [
                "OBS-E2-V2",
                "OBS-LH-V2"
              ],
              "guideline_ids": [
                "GL-EAA-GM-2019",
                "GL-ES-HYPOGONAD-2018"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "hCG, AFP, liver, kidney, and thyroid tests",
              "cadence": "Once, at the initial workup",
              "status": "up_to_date",
              "detail": "All normal at intake two weeks ago",
              "guideline_ids": [
                "GL-EAA-GM-2019",
                "GL-ES-HYPOGONAD-2018"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Testosterone therapy",
              "cadence": "Only for persistent, symptomatic, confirmed testosterone deficiency",
              "status": "not_indicated",
              "detail": "Not given while the axis recovers: it would suppress LH and FSH again and is not indicated for a transient, drug-induced low testosterone",
              "guideline_ids": [
                "GL-EAA-GM-2019",
                "GL-ES-HYPOGONAD-2018"
              ]
            },
            {
              "domain": "referral",
              "measure": "Endocrinology consultation",
              "cadence": "For gynecomastia with abnormal hormone results",
              "status": "completed_today",
              "detail": "Seen today; drug-induced cause confirmed; recovery monitoring agreed",
              "guideline_ids": [
                "GL-EAA-GM-2019",
                "GL-ES-HYPOGONAD-2018"
              ]
            },
            {
              "domain": "survey",
              "measure": "PHQ-9",
              "cadence": "Baseline, then at least monthly during acute treatment; every 2 to 4 weeks in continuation",
              "status": "completed_today",
              "detail": "14, down from 15 at intake",
              "observation_ids": [
                "OBS-PHQ9-V2"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-MDD-2022"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9)",
              "cadence": "Every visit during active treatment",
              "status": "completed_today",
              "detail": "No suicidal thoughts, intent, plan, or behavior since intake; PHQ-9 item 9 scored 0. Protective factors unchanged. Safety plan reviewed: on his phone, with 988 and the clinic number",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-SUICIDE-2024"
              ]
            },
            {
              "domain": "survey",
              "measure": "Bipolar screen at the initial workup",
              "cadence": "Once, at the initial depression workup",
              "status": "completed_today",
              "detail": "Interview found no past manic or hypomanic episode and no family history known to him; no Mood Disorder Questionnaire score is recorded",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-MDD-2022"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Psychotherapy, sleep, running, and social contact",
              "cadence": "Every visit during active treatment",
              "status": "completed_today",
              "detail": "Two sessions with a gay-affirming psychologist; sleep five to six hours; two runs alone",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-MDD-2022",
                "GL-APA-SM-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lithium, anticonvulsant, or antipsychotic monitoring (levels, metabolic tests, AIMS)",
              "cadence": "Only on those drugs",
              "status": "not_indicated",
              "detail": "Not on any of these drugs",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-MDD-2022"
              ]
            }
          ],
          "follow_up": "Review in six weeks with hormone tests and PHQ-9",
          "guideline_ids": [
            "GL-EAA-GM-2019",
            "GL-ES-HYPOGONAD-2018",
            "GL-CMID-2026",
            "GL-MDD-2022",
            "GL-SUICIDE-2024"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Eight-week review of hormone recovery and depression treatment",
        "status": "finished",
        "date": "2026-06-09",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Eight-week review of hormone recovery and depression treatment",
          "hpi": {
            "narrative": "Mr. Turing returns eight weeks after his first visit, about eleven weeks after the last estrogen injection. The breast tenderness is less and he no longer notices it when running. Morning erections returned three weeks ago and his libido is coming back. He has had seven psychotherapy sessions and runs about 25 km a week. His mood is somewhat better, but he still feels flat most days, has little pleasure outside work, and wakes early. He has had no suicidal thoughts. After the last visit he asked to think about medicine; today, after a discussion of sertraline, mirtazapine, and bupropion and their effects on sexual function, weight, sleep, and blood pressure, he chose bupropion. He has no history of seizures, head injury, or an eating disorder and drinks little alcohol.",
            "elements": [
              {
                "label": "Breasts",
                "value": "Less tender; no discharge"
              },
              {
                "label": "Sexual function",
                "value": "Morning erections back for three weeks; libido returning"
              },
              {
                "label": "Psychotherapy",
                "value": "Seven sessions"
              },
              {
                "label": "Running",
                "value": "About 25 km a week"
              },
              {
                "label": "Safety",
                "value": "No suicidal thoughts"
              },
              {
                "label": "PHQ-9",
                "value": "12, down from 15"
              }
            ]
          },
          "ros": [
            {
              "system": "Breast",
              "status": "positive",
              "finding": "Mild tenderness on pressure only; no discharge"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "Erections returning; no testicular symptoms"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No seizures, fainting, or head injury ever"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Flat mood and early waking; no suicidal thoughts, elevated mood, or racing thoughts"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Lean; more animated than at intake"
            },
            {
              "system": "Breast",
              "finding": "Examined with his agreement: glandular tissue about 3 cm behind each nipple, softer and only mildly tender; no discrete mass, skin change, discharge, or nodes"
            },
            {
              "system": "Mental status",
              "finding": "Alert; mood \"better, but grey\"; affect mildly constricted and reactive; thought process linear; no suicidal ideation; insight and judgment good"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Drug-induced hypogonadotropic hypogonadism, recovering",
              "assessment": "LH 2.4 and FSH 3.1 mIU/mL are back in range and testosterone has risen from 112 to 238 ng/dL, still low. Estradiol and prolactin are normal. Hemoglobin has normalized",
              "plan": [
                "Continue watchful recovery without testosterone therapy",
                "Testosterone, LH, FSH, and hemoglobin in eight weeks"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "Bilateral gynecomastia, improving",
              "assessment": "Smaller and less tender now that estradiol is normal",
              "plan": [
                "Continue watchful waiting"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Major depressive disorder, single episode, with partial response at eight weeks",
              "assessment": "PHQ-9 12, down 20 percent from 15 after eight weeks of psychotherapy alone: a partial response. He chose to add an antidepressant. Bupropion suits his wish to avoid sexual side effects and weight change; he has no seizure risk factors. No past mania or hypomania. Suicide risk remains low",
              "plan": [
                "Start bupropion XL 150 mg each morning; nurse telephone check in two weeks for sleep, anxiety, blood pressure, and safety",
                "Continue weekly psychotherapy",
                "Collaborative safety plan reviewed and unchanged; 988 Suicide & Crisis Lifeline and the clinic number confirmed"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Breast examination for size, tenderness, and any discrete mass",
              "cadence": "Every visit until the gynecomastia settles",
              "status": "completed_today",
              "detail": "Glandular tissue about 3 cm behind each nipple, softer, mildly tender; no discrete mass",
              "guideline_ids": [
                "GL-EAA-GM-2019",
                "GL-ES-HYPOGONAD-2018"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Testosterone, estradiol, LH, and FSH",
              "cadence": "Every 6 to 8 weeks after the exposure stops, until normal",
              "status": "completed_today",
              "detail": "Testosterone 238 ng/dL (low, rising); estradiol 26 pg/mL; LH 2.4 and FSH 3.1 mIU/mL, now in range",
              "observation_ids": [
                "OBS-TESTO-V3",
                "OBS-E2-V3",
                "OBS-LH-V3",
                "OBS-FSH-V3"
              ],
              "guideline_ids": [
                "GL-EAA-GM-2019",
                "GL-ES-HYPOGONAD-2018"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Prolactin after the estrogen clears",
              "cadence": "Repeat once after a raised value",
              "status": "completed_today",
              "detail": "12.4 ng/mL, normal, down from 21.6; the rise was estrogen-related",
              "observation_ids": [
                "OBS-PRL-V3"
              ],
              "guideline_ids": [
                "GL-EAA-GM-2019",
                "GL-ES-HYPOGONAD-2018"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hemoglobin while testosterone is low",
              "cadence": "With each hormone check until normal",
              "status": "completed_today",
              "detail": "13.6 g/dL, back in range",
              "observation_ids": [
                "OBS-HGB-V3"
              ],
              "guideline_ids": [
                "GL-EAA-GM-2019",
                "GL-ES-HYPOGONAD-2018"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Testosterone therapy",
              "cadence": "Only for persistent, symptomatic, confirmed testosterone deficiency",
              "status": "not_indicated",
              "detail": "Not given while the axis recovers: it would suppress LH and FSH again and is not indicated for a transient, drug-induced low testosterone",
              "guideline_ids": [
                "GL-EAA-GM-2019",
                "GL-ES-HYPOGONAD-2018"
              ]
            },
            {
              "domain": "survey",
              "measure": "PHQ-9",
              "cadence": "Baseline, then at least monthly during acute treatment; every 2 to 4 weeks in continuation",
              "status": "completed_today",
              "detail": "12, down 20 percent from 15: partial response; bupropion added. Six weeks since the last score, two weeks beyond the monthly interval, because this review was timed to the hormone tests; no harm, as he had weekly therapy sessions and no suicidal thoughts",
              "observation_ids": [
                "OBS-PHQ9-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-MDD-2022"
              ]
            },
            {
              "domain": "survey",
              "measure": "GAD-7",
              "cadence": "With the PHQ-9 when anxiety symptoms were present at baseline",
              "status": "completed_today",
              "detail": "6, down from 8",
              "observation_ids": [
                "OBS-GAD7-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-MDD-2022"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9)",
              "cadence": "Every visit during active treatment",
              "status": "completed_today",
              "detail": "No suicidal thoughts, intent, plan, or behavior since the last visit; PHQ-9 item 9 scored 0. Protective factors unchanged; safety plan reviewed",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-SUICIDE-2024"
              ]
            },
            {
              "domain": "survey",
              "measure": "Bipolar screen before starting an antidepressant",
              "cadence": "At the initial workup; repeat if hypomanic features emerge",
              "status": "completed_today",
              "detail": "Still no history of elevated mood, reduced need for sleep, or racing thoughts",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-MDD-2022"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Antidepressant tolerability check two weeks after starting",
              "cadence": "2 weeks after starting and after each dose change",
              "status": "due",
              "detail": "Nurse telephone check booked for two weeks from today",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-MDD-2022"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Psychotherapy, sleep, running, and social contact",
              "cadence": "Every visit during active treatment",
              "status": "completed_today",
              "detail": "Seven sessions; running about 25 km a week; early waking",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-MDD-2022",
                "GL-APA-SM-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lithium, anticonvulsant, or antipsychotic monitoring (levels, metabolic tests, AIMS)",
              "cadence": "Only on those drugs",
              "status": "not_indicated",
              "detail": "Not on any of these drugs",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-MDD-2022"
              ]
            }
          ],
          "follow_up": "Nurse telephone check in two weeks; review in eight weeks with hormone tests and PHQ-9",
          "guideline_ids": [
            "GL-EAA-GM-2019",
            "GL-ES-HYPOGONAD-2018",
            "GL-CMID-2026",
            "GL-MDD-2022",
            "GL-SUICIDE-2024"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "Sixteen-week review of hormone recovery and depression treatment",
        "status": "finished",
        "date": "2026-08-04",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Sixteen-week review of hormone recovery and depression treatment",
          "hpi": {
            "narrative": "Mr. Turing returns eight weeks after starting bupropion XL 150 mg. The nurse telephone check planned for two weeks after the start did not happen: he was abroad at a conference, two calls went unanswered, and no further call was booked. He had a dry mouth and some difficulty falling asleep in the first week, which settled when he took the tablet earlier in the morning, and no headache, tremor, or restlessness. He has missed no doses. His mood is clearly better: he enjoys running again, at about 35 km a week, and has started working on a new problem with real pleasure. He sleeps about seven hours. Libido and erections are back to his usual. He has had fourteen psychotherapy sessions. The breast tissue is smaller and tender only when pressed. He has had no suicidal thoughts.",
            "elements": [
              {
                "label": "Missed contact",
                "value": "Two-week nurse call after starting bupropion not completed"
              },
              {
                "label": "Bupropion",
                "value": "Dry mouth and trouble falling asleep in week one, now settled; no missed doses"
              },
              {
                "label": "Sexual function",
                "value": "Libido and erections back to his usual"
              },
              {
                "label": "Running",
                "value": "About 35 km a week"
              },
              {
                "label": "Safety",
                "value": "No suicidal thoughts"
              },
              {
                "label": "PHQ-9",
                "value": "7, down from 15"
              }
            ]
          },
          "ros": [
            {
              "system": "Breast",
              "status": "negative",
              "finding": "Tender only when pressed; no discharge"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No headache, tremor, or seizures"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No palpitations"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Mild residual low mood on some days; no suicidal thoughts, elevated mood, or racing thoughts"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; brisk"
            },
            {
              "system": "Breast",
              "finding": "Examined with his agreement: glandular tissue about 2.5 cm behind the left nipple and 1.5 cm behind the right, tender only on firm pressure; no discrete mass"
            },
            {
              "system": "Mental status",
              "finding": "Alert; mood \"much more like myself\"; affect reactive with humor; thought process linear; no suicidal ideation; insight and judgment good"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Drug-induced hypogonadotropic hypogonadism, resolved",
              "assessment": "Testosterone 452 ng/dL with LH 4.8 and FSH 5.2 mIU/mL: the axis has recovered without treatment, about four months after the last estrogen injection. Hemoglobin 14.4 g/dL",
              "plan": [
                "No further hormone tests needed except testosterone and estradiol once more at six months",
                "Bone density scan not needed, as the hypogonadism lasted under six months"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "Bilateral gynecomastia, improving",
              "assessment": "Continuing to shrink",
              "plan": [
                "Continue watchful waiting; review at six months"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Major depressive disorder, single episode, responding",
              "assessment": "PHQ-9 7, down 53 percent from 15: a response, not yet remission. Bupropion is well tolerated; blood pressure 124/78 mmHg. Suicide risk remains low",
              "plan": [
                "Continue bupropion XL 150 mg; psychotherapy to the end of the course of 16 sessions, then monthly",
                "Collaborative safety plan reviewed and unchanged; 988 Suicide & Crisis Lifeline and the clinic number confirmed"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Breast examination for size, tenderness, and any discrete mass",
              "cadence": "Every visit until the gynecomastia settles",
              "status": "completed_today",
              "detail": "Glandular tissue about 2.5 cm on the left and 1.5 cm on the right, tender only on firm pressure; no discrete mass",
              "guideline_ids": [
                "GL-EAA-GM-2019",
                "GL-ES-HYPOGONAD-2018"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Testosterone, LH, and FSH",
              "cadence": "Every 6 to 8 weeks after the exposure stops, until normal",
              "status": "completed_today",
              "detail": "Testosterone 452 ng/dL, LH 4.8 and FSH 5.2 mIU/mL: all normal; recovery complete",
              "observation_ids": [
                "OBS-TESTO-V4",
                "OBS-LH-V4",
                "OBS-FSH-V4"
              ],
              "guideline_ids": [
                "GL-EAA-GM-2019",
                "GL-ES-HYPOGONAD-2018"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hemoglobin while testosterone is low",
              "cadence": "With each hormone check until normal",
              "status": "completed_today",
              "detail": "14.4 g/dL",
              "observation_ids": [
                "OBS-HGB-V4"
              ],
              "guideline_ids": [
                "GL-EAA-GM-2019",
                "GL-ES-HYPOGONAD-2018"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Bone density (DXA)",
              "cadence": "If hypogonadism persists beyond six months or a fragility fracture occurs",
              "status": "not_indicated",
              "detail": "The axis recovered within about four months of the last estrogen dose",
              "guideline_ids": [
                "GL-ES-OSTEO-MEN-2012",
                "GL-ES-HYPOGONAD-2018"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Testosterone therapy",
              "cadence": "Only for persistent, symptomatic, confirmed testosterone deficiency",
              "status": "not_indicated",
              "detail": "Not given while the axis recovers: it would suppress LH and FSH again and is not indicated for a transient, drug-induced low testosterone",
              "guideline_ids": [
                "GL-EAA-GM-2019",
                "GL-ES-HYPOGONAD-2018"
              ]
            },
            {
              "domain": "survey",
              "measure": "PHQ-9",
              "cadence": "Baseline, then at least monthly during acute treatment; every 2 to 4 weeks in continuation",
              "status": "completed_today",
              "detail": "7, down 53 percent from 15: response; remission not yet reached",
              "observation_ids": [
                "OBS-PHQ9-V4"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-MDD-2022"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9)",
              "cadence": "Every visit during active treatment",
              "status": "completed_today",
              "detail": "No suicidal thoughts, intent, plan, or behavior since the last visit; PHQ-9 item 9 scored 0. Safety plan reviewed",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-SUICIDE-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Antidepressant tolerability check two weeks after starting",
              "cadence": "2 weeks after starting and after each dose change",
              "status": "deferred",
              "detail": "Not done, a deviation from the protocol: the nurse telephone check two weeks after bupropion was started, which was also to supply the monthly PHQ-9, was not completed after two unanswered calls while he was abroad, and no further call was booked, leaving eight weeks without a score. No harm resulted judging by today's review: the early insomnia and dry mouth settled, blood pressure is 124/78 mmHg, and there were no suicidal thoughts. Corrective action: a missed safety call is now rebooked within two days and flagged to Dr. Hallam if it cannot be completed",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-MDD-2022"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Adherence, adverse effects, and blood pressure on bupropion",
              "cadence": "Every visit during active treatment",
              "status": "completed_today",
              "detail": "No missed doses; early dry mouth and insomnia settled; blood pressure 124/78 mmHg",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-MDD-2022"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Psychotherapy, sleep, running, and social contact",
              "cadence": "Every visit during active treatment",
              "status": "completed_today",
              "detail": "Fourteen sessions; sleep about seven hours; running about 35 km a week",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-MDD-2022",
                "GL-APA-SM-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lithium, anticonvulsant, or antipsychotic monitoring (levels, metabolic tests, AIMS)",
              "cadence": "Only on those drugs",
              "status": "not_indicated",
              "detail": "Not on any of these drugs",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-MDD-2022"
              ]
            }
          ],
          "follow_up": "Six-month review in two months with testosterone, estradiol, vitamin D, and PHQ-9",
          "guideline_ids": [
            "GL-EAA-GM-2019",
            "GL-ES-HYPOGONAD-2018",
            "GL-ES-OSTEO-MEN-2012",
            "GL-CMID-2026",
            "GL-MDD-2022",
            "GL-SUICIDE-2024"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "Six-month review of gynecomastia and depression in continuation treatment",
        "status": "finished",
        "date": "2026-10-06",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Six-month review of gynecomastia and depression in continuation treatment",
          "hpi": {
            "narrative": "Mr. Turing returns about six months after his first visit. His right ankle sprain from August healed within three weeks and he is back to about 40 km a week. He has finished the course of 16 psychotherapy sessions and now sees the psychologist monthly. He feels like himself, sleeps about seven hours, and has been changing at his running club again for a month. He takes bupropion XL 150 mg and cholecalciferol every morning, has missed no doses, and has no side effects. The breast tissue is no longer tender, though he can still feel a small disc on the left. He has had no suicidal thoughts.",
            "elements": [
              {
                "label": "Interval change",
                "value": "Feels like himself; back with his running club"
              },
              {
                "label": "Ankle",
                "value": "Sprain healed within three weeks"
              },
              {
                "label": "Psychotherapy",
                "value": "Course of 16 sessions finished; monthly sessions now"
              },
              {
                "label": "Breasts",
                "value": "No tenderness; small disc on the left"
              },
              {
                "label": "Safety",
                "value": "No suicidal thoughts"
              },
              {
                "label": "PHQ-9",
                "value": "4"
              }
            ]
          },
          "ros": [
            {
              "system": "Breast",
              "status": "negative",
              "finding": "No tenderness or discharge"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "Libido and erections normal"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "Ankle recovered"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; no suicidal thoughts, elevated mood, or racing thoughts"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well, lean, and cheerful"
            },
            {
              "system": "Breast",
              "finding": "Examined with his agreement: a soft, non-tender disc of glandular tissue about 2 cm behind the left nipple and 1 cm behind the right; no discrete mass, skin change, discharge, or nodes"
            },
            {
              "system": "Mental status",
              "finding": "Alert; mood \"good\"; affect full and reactive; thought process linear; no suicidal ideation; insight and judgment good"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "Residual gynecomastia, improving",
              "assessment": "Small and non-tender six months after the estrogen stopped. Testosterone 536 ng/dL and estradiol 24 pg/mL are normal",
              "plan": [
                "Watchful waiting to about twelve months after the estrogen stopped; if the tissue persists and he wants it removed, a plastic surgery opinion, because long-standing gynecomastia becomes fibrous and seldom regresses"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Vitamin D insufficiency, resolved",
              "assessment": "25-hydroxyvitamin D 38 ng/mL on cholecalciferol 1,000 units",
              "plan": [
                "Continue cholecalciferol 1,000 units daily through the winter"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Major depressive disorder, single episode, in remission",
              "assessment": "PHQ-9 4: remission about six months after starting psychotherapy and four months after adding bupropion. Suicide risk remains low, with protective factors stronger than at intake",
              "plan": [
                "Continue bupropion XL 150 mg for at least six months after remission, then decide together about tapering",
                "Monthly psychotherapy; PHQ-9 every two to three months",
                "Collaborative safety plan reviewed and unchanged; 988 Suicide & Crisis Lifeline and the clinic number confirmed"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Breast examination for size, tenderness, and any discrete mass",
              "cadence": "Every visit until the gynecomastia settles",
              "status": "completed_today",
              "detail": "A soft, non-tender disc about 2 cm on the left and 1 cm on the right; no discrete mass",
              "guideline_ids": [
                "GL-EAA-GM-2019",
                "GL-ES-HYPOGONAD-2018"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Testosterone and estradiol at six months",
              "cadence": "Once, to confirm sustained recovery",
              "status": "completed_today",
              "detail": "Testosterone 536 ng/dL and estradiol 24 pg/mL, normal",
              "observation_ids": [
                "OBS-TESTO-V5",
                "OBS-E2-V5"
              ],
              "guideline_ids": [
                "GL-EAA-GM-2019",
                "GL-ES-HYPOGONAD-2018"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "25-hydroxyvitamin D on replacement",
              "cadence": "About three to six months after starting",
              "status": "completed_today",
              "detail": "38 ng/mL, up from 22",
              "observation_ids": [
                "OBS-VITD-V5"
              ],
              "guideline_ids": [
                "GL-ES-OSTEO-MEN-2012",
                "GL-ES-HYPOGONAD-2018"
              ]
            },
            {
              "domain": "referral",
              "measure": "Surgical opinion for persistent gynecomastia",
              "cadence": "If it persists about twelve months and troubles him",
              "status": "due",
              "detail": "Not yet: six months since the estrogen stopped and still shrinking",
              "guideline_ids": [
                "GL-EAA-GM-2019",
                "GL-ES-HYPOGONAD-2018"
              ]
            },
            {
              "domain": "survey",
              "measure": "PHQ-9",
              "cadence": "Baseline, then at least monthly during acute treatment; every 2 to 4 weeks in continuation",
              "status": "completed_today",
              "detail": "4: remission",
              "observation_ids": [
                "OBS-PHQ9-V5"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-MDD-2022"
              ]
            },
            {
              "domain": "survey",
              "measure": "Monthly PHQ-9 between the sixteen-week review and today",
              "cadence": "At least monthly during acute treatment",
              "status": "deferred",
              "detail": "Not done, a deviation from the protocol: no interim PHQ-9 was scheduled after the response at sixteen weeks, although remission had not been reached, leaving nine weeks unmeasured. No harm resulted judging by today's review: he reached remission and had no suicidal thoughts, and he saw the psychologist throughout. Corrective action: the clinic registry now books a monthly PHQ-9 call until a remission score is recorded",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-MDD-2022"
              ]
            },
            {
              "domain": "survey",
              "measure": "GAD-7",
              "cadence": "With the PHQ-9 when anxiety symptoms were present at baseline",
              "status": "completed_today",
              "detail": "3",
              "observation_ids": [
                "OBS-GAD7-V5"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-MDD-2022"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9)",
              "cadence": "Every visit during active treatment",
              "status": "completed_today",
              "detail": "No suicidal thoughts, intent, plan, or behavior since the last visit; PHQ-9 item 9 scored 0. Protective factors stronger than at intake. Safety plan reviewed",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-SUICIDE-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Adherence, adverse effects, and blood pressure on bupropion",
              "cadence": "Every visit during active treatment",
              "status": "completed_today",
              "detail": "No missed doses; no side effects; blood pressure 118/72 mmHg",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-MDD-2022"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Psychotherapy, sleep, running, and social contact",
              "cadence": "Every visit during active treatment",
              "status": "completed_today",
              "detail": "Course of 16 sessions finished, monthly now; sleep about seven hours; running 40 km a week with his club",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-MDD-2022",
                "GL-APA-SM-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lithium, anticonvulsant, or antipsychotic monitoring (levels, metabolic tests, AIMS)",
              "cadence": "Only on those drugs",
              "status": "not_indicated",
              "detail": "Not on any of these drugs",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-MDD-2022"
              ]
            }
          ],
          "follow_up": "Preventive visit in two weeks; depression review with PHQ-9 in about two months",
          "guideline_ids": [
            "GL-EAA-GM-2019",
            "GL-ES-HYPOGONAD-2018",
            "GL-ES-OSTEO-MEN-2012",
            "GL-CMID-2026",
            "GL-MDD-2022",
            "GL-SUICIDE-2024"
          ]
        }
      },
      {
        "id": "ENC-006",
        "display": "Same-day sick visit for a right ankle sprain",
        "status": "finished",
        "date": "2026-08-25",
        "visit_type": "sick",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "185345009",
          "display": "Encounter for symptom",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Right ankle pain after turning it on a trail run yesterday",
          "billing_note": "Problem-oriented office visit, established patient",
          "hpi": {
            "narrative": "Mr. Turing is a 41-year-old mathematician recovering from the effects of a year of high-dose estrogen given without his consent, and in treatment for a moderate depressive episode with psychotherapy and bupropion XL 150 mg, who asked for a same-day visit. Yesterday evening, about 12 km into a trail run, he turned his right foot inward on a root and felt pain on the outside of the ankle. He walked the last kilometer home slowly. The ankle swelled overnight. The pain is 5 of 10, on the outer side, worse on walking and eased by rest and ice. He heard no pop, did not fall, and has no numbness or calf pain. He has had no earlier ankle injuries. His mood has stayed much better; he is frustrated mainly because running has been his most reliable way of managing his mood, and he is worried about losing it. He has had no suicidal thoughts.",
            "elements": [
              {
                "label": "Mechanism",
                "value": "Inversion injury on a trail run yesterday evening"
              },
              {
                "label": "Location",
                "value": "Outer right ankle; no foot or calf pain"
              },
              {
                "label": "Severity",
                "value": "5 of 10; walked home slowly"
              },
              {
                "label": "Medicines",
                "value": "Bupropion XL 150 mg and cholecalciferol; no pain medicine taken yet"
              },
              {
                "label": "Mood",
                "value": "Much improved; worried about losing running; no suicidal thoughts"
              }
            ]
          },
          "ros": [
            {
              "system": "Musculoskeletal",
              "status": "positive",
              "finding": "Right ankle pain and swelling; no knee, foot, or calf pain"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No numbness or tingling in the foot"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No wound or skin break"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; sleeping about seven hours; no suicidal thoughts"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Comfortable at rest; walks into the room with a mild limp, bearing weight on the right"
            },
            {
              "system": "Right ankle",
              "finding": "Swelling and tenderness over the anterior talofibular ligament; no tenderness along the posterior edge or tip of either malleolus, at the base of the fifth metatarsal, or over the navicular; anterior drawer test painful but with a firm end point"
            },
            {
              "system": "Leg",
              "finding": "Calf soft and non-tender; squeeze test negative; Achilles tendon intact"
            },
            {
              "system": "Neurovascular",
              "finding": "Dorsalis pedis pulse strong; sensation normal"
            },
            {
              "system": "Mental status",
              "finding": "Wry and engaged; mood \"good, apart from the ankle\"; no suicidal ideation"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-006",
              "display": "Right lateral ankle sprain",
              "assessment": "Mild to moderate lateral ligament sprain. He can bear weight and has no bony tenderness at the malleoli, the base of the fifth metatarsal, or the navicular, so the Ottawa ankle rules say no X-ray is needed. No sign of a high ankle sprain or Achilles injury",
              "plan": [
                "Ice for 15 minutes several times a day for two days, compression wrap, and elevation; walk as comfort allows",
                "Ibuprofen 400 mg up to three times a day with food for no more than 5 days; no interaction with bupropion",
                "Ankle range-of-motion and balance exercises from the third day; a lace-up brace for running for six weeks",
                "Cycling or swimming in place of running for about two weeks, then a graded return on even ground",
                "Return if he cannot bear weight, if the pain is worse after a week, or if bony tenderness develops"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Major depressive disorder, single episode, improving",
              "assessment": "Responding to psychotherapy and bupropion. A pause from running is a risk to his routine, so other exercise is planned. Safety reviewed: no suicidal thoughts, intent, or plan; protective factors unchanged",
              "plan": [
                "Continue bupropion XL 150 mg and psychotherapy",
                "Swim or cycle on the days he would have run, and keep meeting his running friends",
                "Collaborative safety plan reviewed and unchanged; 988 Suicide & Crisis Lifeline and the clinic number confirmed"
              ]
            }
          ],
          "follow_up": "Return if not improving in a week or at once for the warning signs above. Six-month review in October",
          "guideline_ids": [
            "GL-OTTAWA-1992",
            "GL-MDD-2022",
            "GL-SUICIDE-2024"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic unscheduled sick visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T11:00:00-05:00"
        }
      },
      {
        "id": "ENC-007",
        "display": "Periodic adult preventive visit",
        "status": "finished",
        "date": "2026-10-20",
        "visit_type": "preventive_adult",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "86013001",
          "display": "Periodic reevaluation and management of healthy individual",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Periodic preventive visit; no new complaints",
          "billing_note": "CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning), both on the same day",
          "hpi": {
            "narrative": "Mr. Turing is a 41-year-old mathematician who comes for his periodic preventive visit two weeks after his six-month review. He completed the health risk assessment before the visit. His ankle recovered within three weeks of the August visit; he took ibuprofen for four days and is back to about 40 km a week. His depression is in remission on bupropion XL 150 mg with monthly psychotherapy sessions, and his testosterone has been normal since August. The breast tissue is no longer tender. He has had no suicidal thoughts. He has not had HIV or STI testing since moving here and would like it today. He has had one new male partner in the past three months and uses condoms most of the time.",
            "elements": [
              {
                "label": "Visit",
                "value": "Periodic adult preventive visit, age 41"
              },
              {
                "label": "Safety events",
                "value": "No falls, emergency visits, or hospital stays this year"
              },
              {
                "label": "Medicines",
                "value": "Bupropion XL 150 mg and cholecalciferol 1,000 units daily; ibuprofen for four days in August"
              },
              {
                "label": "Active conditions",
                "value": "Depression in remission; small residual gynecomastia; ankle sprain resolved"
              },
              {
                "label": "Sexual health",
                "value": "One new male partner in three months; condoms most of the time; asks for HIV and STI testing"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Good, much better than in the spring"
            },
            {
              "domain": "Psychosocial",
              "finding": "Sees friends weekly; back with his running club; no current legal proceedings"
            },
            {
              "domain": "Tobacco",
              "finding": "Never used tobacco"
            },
            {
              "domain": "Alcohol and drugs",
              "finding": "Two or three drinks a week (AUDIT-C 2); no drug use"
            },
            {
              "domain": "Physical activity",
              "finding": "Running about 40 km a week with weekly strength work"
            },
            {
              "domain": "Nutrition",
              "finding": "Regular meals; calcium from dairy most days"
            },
            {
              "domain": "Sleep",
              "finding": "About seven hours a night"
            },
            {
              "domain": "Sexual health",
              "finding": "One new male partner in the past three months; condoms most of the time; no symptoms"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent"
            },
            {
              "domain": "Instrumental activities of daily living",
              "finding": "Independent"
            },
            {
              "domain": "Home safety",
              "finding": "Smoke detectors working; no firearms in the home"
            },
            {
              "domain": "Hearing and vision",
              "finding": "No concerns"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Weight steady; no fever or fatigue"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No change in vision"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No hearing loss, sore throat, or mouth ulcers"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain or palpitations when running"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No abdominal pain, change in bowel habit, or rectal symptoms"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No urethral discharge, dysuria, or genital sores; libido and erections back to his usual"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "Ankle recovered"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash or new skin lesions"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No headaches or numbness"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-9 3 with item 9 scored 0; no suicidal thoughts"
            },
            {
              "system": "Breast",
              "status": "negative",
              "finding": "No breast pain, new lump, or nipple discharge"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Well and lean; weight 68.5 kg, BMI 21.6"
            },
            {
              "system": "Neck",
              "finding": "No thyroid enlargement or nodes"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm at 54 per minute, as expected in a trained runner; no murmur"
            },
            {
              "system": "Respiratory",
              "finding": "Clear"
            },
            {
              "system": "Breast",
              "finding": "Examined with his agreement: a soft disc of glandular tissue about 2 cm behind the left nipple and 1 cm behind the right, non-tender; no discrete mass, skin change, nipple discharge, or axillary nodes"
            },
            {
              "system": "Abdomen",
              "finding": "Soft and non-tender"
            },
            {
              "system": "Genitourinary",
              "finding": "Offered and declined today; no symptoms"
            },
            {
              "system": "Skin",
              "finding": "No rash or suspicious lesions"
            },
            {
              "system": "Musculoskeletal",
              "finding": "Right ankle stable with full range of motion"
            },
            {
              "system": "Mental status",
              "finding": "Relaxed, humorous, and engaged; euthymic; no suicidal ideation"
            }
          ],
          "assessment_plan": [
            {
              "display": "Periodic preventive visit, age 41",
              "assessment": "Health risk assessment reviewed and a written prevention plan given. Ten-year cardiovascular risk is under 2 percent by the pooled cohort equations, so a statin is not recommended. Sexual health care offered as routine adult care",
              "plan": [
                "HIV, syphilis, hepatitis B and C serology, and urine, pharyngeal, and rectal gonorrhea and chlamydia tests drawn today with his consent; he will be told the results by secure message",
                "PrEP explained: with one partner, condoms most of the time, and no recent STI he does not now meet the indications, and he will tell us if that changes; PrEP is available here whenever it is right for him",
                "Next preventive visit in one year"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Major depressive disorder, single episode, in remission",
              "assessment": "PHQ-9 3, in remission on bupropion with psychotherapy. Safety reviewed: no suicidal thoughts, intent, or plan; protective factors stronger than at intake",
              "plan": [
                "Continue bupropion XL 150 mg for at least six to nine months after remission, then decide together whether to taper",
                "Collaborative safety plan reviewed and unchanged, with the 988 Suicide & Crisis Lifeline and the clinic number"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "Residual gynecomastia, improving",
              "assessment": "Smaller and non-tender, six months after the estrogen stopped",
              "plan": [
                "Watchful waiting; a plastic surgery opinion if it persists about twelve months after the estrogen stopped and he wants it removed"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Blood pressure",
              "status": "completed_today",
              "detail": "116/72 mmHg",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Cholesterol and statin decision",
              "status": "completed_today",
              "detail": "Total cholesterol 182, HDL 62, LDL 104, triglycerides 80 mg/dL; ten-year risk under 2 percent, so no statin; repeat in five years",
              "guideline_ids": [
                "GL-USPSTF-STATIN-2022"
              ]
            },
            {
              "service": "Diabetes screening",
              "status": "not_indicated",
              "detail": "BMI 21.6 with no other risk factors; screening is for adults 35 to 70 with overweight or obesity",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "HIV screening",
              "status": "ordered",
              "detail": "HIV antigen and antibody test drawn today with his consent",
              "guideline_ids": [
                "GL-USPSTF-HIV-2019",
                "GL-CDC-STI-2021"
              ]
            },
            {
              "service": "Syphilis, gonorrhea, and chlamydia testing",
              "status": "ordered",
              "detail": "Syphilis serology and urine, pharyngeal, and rectal NAATs by site of exposure, drawn today with his consent; yearly while sexually active, more often if his risk changes",
              "guideline_ids": [
                "GL-USPSTF-SYPH-2022",
                "GL-CDC-STI-2021"
              ]
            },
            {
              "service": "Hepatitis C screening",
              "status": "ordered",
              "detail": "One-time antibody test drawn today",
              "guideline_ids": [
                "GL-USPSTF-HCV-2020"
              ]
            },
            {
              "service": "Hepatitis B screening and vaccination",
              "status": "ordered",
              "detail": "HBsAg, core antibody, and surface antibody drawn today; vaccinate if not immune",
              "guideline_ids": [
                "GL-CDC-STI-2021",
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "HIV preexposure prophylaxis",
              "status": "not_indicated",
              "detail": "Discussed as routine care; he does not meet the indications now; to be revisited at any visit he wishes",
              "guideline_ids": [
                "GL-USPSTF-PREP-2023",
                "GL-CDC-STI-2021"
              ]
            },
            {
              "service": "Colorectal cancer screening",
              "status": "not_indicated",
              "detail": "Begins at 45; no family history recorded",
              "guideline_ids": [
                "GL-USPSTF-CRC-2021"
              ]
            },
            {
              "service": "Lung cancer and abdominal aortic aneurysm screening",
              "status": "not_indicated",
              "detail": "Never used tobacco",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Depression screening and monitoring",
              "status": "completed_today",
              "detail": "PHQ-9 3 in continuation treatment; item 9 scored 0",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-MDD-2022"
              ]
            },
            {
              "service": "Unhealthy alcohol use screening",
              "status": "completed_today",
              "detail": "AUDIT-C 2",
              "guideline_ids": [
                "GL-USPSTF-ALC-2018"
              ]
            },
            {
              "service": "Influenza vaccine, this season",
              "status": "completed_today",
              "detail": "Given today with his consent",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "COVID-19 vaccine, this season",
              "status": "due",
              "detail": "Recommended; he will have it at a pharmacy next week",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Hepatitis A vaccine",
              "status": "due",
              "detail": "Recommended for men who have sex with men; first dose at his next visit after he has thought it over",
              "guideline_ids": [
                "GL-CDC-IMZ-2026",
                "GL-CDC-STI-2021"
              ]
            },
            {
              "service": "HPV vaccine",
              "status": "due",
              "detail": "Shared decision for adults 27 to 45; he will decide at his next visit",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Tetanus, diphtheria, and pertussis booster",
              "status": "up_to_date",
              "detail": "Tdap five years ago",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Dental examination",
              "status": "due",
              "detail": "No dental visit since moving here; he will book one"
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 20 minutes, with his consent. He named a health care agent, a close friend, and completed a health care proxy form; the agent is recorded in the chart and is not named here. He said that what matters most to him is being able to think and work, and that no treatment should ever be given to him without his own agreement or, if he cannot speak, his agent's. He wants full treatment for reversible illness. He asked that his records, including his sexual orientation and the history of the estrogen he was given, be shared only with clinicians treating him. The plan will be revisited yearly.",
          "follow_up": "Results by secure message within a week. COVID-19 vaccine at a pharmacy. Hepatitis A and HPV vaccine decisions at the next visit. Depression review in about two months. Next preventive visit in one year",
          "guideline_ids": [
            "GL-PREV-2026",
            "GL-USPSTF-AB",
            "GL-CDC-IMZ-2026",
            "GL-CDC-STI-2021",
            "GL-APA-SM-2021"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic periodic preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T11:00:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-04-14",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 178,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 71.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 22.5,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 122,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 76,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 64,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs; no measured height, weight, or blood pressure from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-04-28",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 178,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 71.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 22.4,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 120,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 74,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 62,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.5,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs; no measured height, weight, or blood pressure from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-06-09",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 178,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 70.1,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 22.1,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 118,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 74,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 58,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs; no measured height, weight, or blood pressure from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-08-04",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 178,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 69.3,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.9,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 124,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 60,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs; no measured height, weight, or blood pressure from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-10-06",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 178,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 68.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.7,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 118,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 72,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 54,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs; no measured height, weight, or blood pressure from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "VSET-006",
        "date": "2026-08-25",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 178,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 69.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.8,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 126,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 70,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs at the sick visit, raised slightly by pain.",
          "author": "The Human Record generator",
          "created": "2026-11-04T11:00:00-05:00"
        }
      },
      {
        "id": "VSET-007",
        "date": "2026-10-20",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 178,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 68.5,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.6,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 116,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 72,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 54,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T11:00:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Occupation: mathematician and computer scientist; moved here three months ago to a university research post, after a criminal conviction abroad for a consensual relationship with another adult man under a law that criminalizes sex between men",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic modern occupation and circumstances echoing his documented prosecution and his work at Manchester.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Sexual orientation: gay; pronouns he/him; lives alone; not in a relationship now; has one or two close friends here and others abroad",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic social history recorded as part of affirming care; orientation is not a diagnosis; names no real person.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Long-distance runner, usually 40 to 50 km a week; has run less in recent months and stopped changing at the running club because of his chest",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic activity history echoing his documented distance running.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Never smoker; two or three drinks a week; no drug use",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic substance-use history.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "SOC-005",
        "display": "Supports: absorbing research work, running, a few trusted friends, and a willingness to talk to a therapist; no firearms in the home",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic strengths and supports; names no real person.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "At intake, working full days but sleeping badly, avoiding the running club changing room, and seeing friends less",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic functional impact of the gynecomastia and the depressive episode.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Tall, lean, casually dressed; slightly hesitant speech that becomes quick and precise on technical subjects; wry humor; cooperative",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "MSE-002",
        "display": "Mood \"flattened, and angry about what was done to me\"; affect constricted, reactive; thought process linear; no suicidal ideation, intent, or plan; no psychotic features; insight and judgment good",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      }
    ],
    "safety_assessment": {
      "id": "SAFE-001",
      "date": "2026-04-14",
      "current_ideation": "absent",
      "intent": "absent",
      "plan": "absent",
      "access_reviewed": true,
      "protective_factors": [
        "Strong engagement in his research",
        "Running and a wish to return to racing",
        "A few trusted friends",
        "Help-seeking and agreement to psychotherapy",
        "No firearms in the home"
      ],
      "disposition": "Outpatient care with a collaborative safety plan, the 988 Suicide & Crisis Lifeline, and a two-week follow-up",
      "provenance": {
        "evidence_grade": "S",
        "claim_ids": [],
        "synthetic_reason": "Synthetic present-day safety assessment; no historical self-harm claim is inferred, and the disputed circumstances of his death are not echoed.",
        "author": "The Human Record generator",
        "created": "2026-11-04T10:00:00-05:00"
      }
    },
    "consultation": {
      "referral": {
        "question": "Bilateral tender gynecomastia, suppressed testosterone and gonadotropins, and low libido in a 40-year-old man three weeks after the last of a year of high-dose estrogen injections given without his free consent. Please confirm the cause, advise what further tests are needed, and advise on recovery, testosterone therapy, bone health, and surgery",
        "urgency": "Soon, within two weeks",
        "pertinent_history": "For about a year, until three weeks ago, he received high-dose estrogen injections abroad as a condition imposed after a criminal conviction for a consensual relationship with another adult man; he did not freely consent and wants no further doses. Over that year his breasts enlarged and became tender, his libido and erections disappeared, and his running fell off. Examination today shows firm, tender, symmetric glandular tissue about 4 cm across behind each nipple, with no discrete mass, skin change, discharge, or axillary nodes, and soft, slightly small testes without masses. Total testosterone 112 ng/dL, estradiol 148 pg/mL, LH 0.3 and FSH 0.4 mIU/mL, prolactin 21.6 ng/mL, SHBG 88 nmol/L, hCG beta 1 mIU/mL, AFP 2.6 ng/mL, liver tests, creatinine, and TSH normal, hemoglobin 13.0 g/dL, and 25-hydroxyvitamin D 22 ng/mL. He takes no other medicine, anabolic steroid, or supplement, and drinks two or three drinks a week. He is also being treated here for a moderate depressive episode, with psychotherapy; PHQ-9 15 with no suicidal ideation. Cholecalciferol 1,000 units daily was started today. He is a long-distance runner and a gay man; he asks that every test and treatment be explained to him first",
        "questions": [
          "Does the exogenous estrogen fully explain the gynecomastia and the hormone results, and what further tests are needed to exclude another cause?",
          "How quickly should the hypothalamic-pituitary-gonadal axis recover, and how should we monitor it?",
          "Is testosterone therapy, tamoxifen, or an aromatase inhibitor indicated now?",
          "Is the raised prolactin significant?",
          "How should we protect and assess his bone health?",
          "When should surgery be considered if the gynecomastia persists?"
        ]
      },
      "consultant_note": {
        "history": "Mr. Turing is seen at the request of Dr. Hallam, five weeks after the last of about a year of high-dose estrogen injections that were imposed on him abroad as the alternative to imprisonment. He did not consent freely and will not take them again. Breast enlargement began within a few months of the injections and became tender; libido and erections were lost over the same months. He has no testicular pain or swelling, nipple discharge, headache, visual disturbance, or galactorrhea. He has never used anabolic steroids, androgens, or other drugs linked to gynecomastia and has no liver, kidney, or thyroid disease. He has had no leg swelling, chest pain, or breathlessness. He runs 20 to 40 km a week. His sexual orientation was discussed only as he chose; it has no bearing on these findings. He asked for each step of the examination to be explained, and agreed to each",
        "data_reviewed": "The intake results, today's estradiol of 46 pg/mL and LH of 0.9 mIU/mL, and today's scrotal ultrasound, which shows testes of about 15 mL each, homogeneous, with no mass and no varicocele",
        "exam": [
          {
            "system": "General",
            "finding": "Tall, lean man; normal male hair distribution"
          },
          {
            "system": "Breast",
            "finding": "Examined with his agreement: firm, tender, rubbery, symmetric glandular tissue about 4 cm across behind each nipple; no discrete or eccentric mass, skin change, nipple discharge, or axillary nodes"
          },
          {
            "system": "Genitourinary",
            "finding": "Examined with his agreement: testes soft and slightly small without masses, as the ultrasound confirms"
          },
          {
            "system": "Neck",
            "finding": "No thyroid enlargement"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-001",
            "display": "Bilateral gynecomastia",
            "assessment": "True gynecomastia, typical on examination and fully explained by a year of high-dose exogenous estrogen. hCG and AFP are normal and the scrotal ultrasound shows no mass, so a testicular tumor is excluded; liver, kidney, and thyroid disease are excluded. Breast imaging is not needed because the examination is typical and shows no discrete mass. Most gynecomastia of recent onset regresses once the cause is removed, though tissue present for many months may become fibrous and persist"
          },
          {
            "problem_id": "PRB-002",
            "display": "Drug-induced hypogonadotropic hypogonadism",
            "assessment": "Suppression of LH, FSH, and testosterone by exogenous estrogen, with estradiol already falling. Recovery is expected over two to six months. Testosterone therapy would suppress the axis again and is not indicated for a transient, drug-induced deficiency. Tamoxifen and aromatase inhibitors are not justified in general and are not needed here. The mildly raised prolactin is an expected estrogen effect and should be rechecked after the estrogen clears; no pituitary imaging is needed unless it stays raised"
          },
          {
            "problem_id": "PRB-003",
            "display": "Adverse effects of high-dose estrogen given without free consent",
            "assessment": "An iatrogenic harm. He has no symptoms or signs of venous thrombosis, and his liver tests are normal. The treatment had no medical indication"
          },
          {
            "problem_id": "PRB-005",
            "display": "Vitamin D insufficiency",
            "assessment": "Appropriate to replace while testosterone is low"
          }
        ],
        "recommendations": [
          "No further estrogen; watchful waiting for the gynecomastia",
          "No testosterone therapy, tamoxifen, or aromatase inhibitor while the axis recovers",
          "Testosterone, estradiol, LH, FSH, prolactin, and hemoglobin about six weeks from now, then every six to eight weeks until normal; testosterone and estradiol once more at about six months",
          "Continue cholecalciferol 1,000 units daily, calcium from food, and running with strength work; a bone density scan only if hypogonadism persists beyond six months or a fragility fracture occurs",
          "Breast imaging only if the examination becomes equivocal or a discrete mass appears",
          "A plastic surgery opinion if the gynecomastia persists about twelve months after the estrogen stopped and he wants it removed",
          "Return to endocrinology if testosterone remains low or LH and FSH have not recovered six months after the last dose, or if prolactin stays raised"
        ],
        "communication": "Discussed with Dr. Hallam the same day; Mr. Turing agrees with the plan and has a written copy",
        "follow_up": "Primary care monitors recovery. Endocrinology is available for review on the criteria above"
      },
      "guideline_ids": [
        "GL-EAA-GM-2019",
        "GL-ES-HYPOGONAD-2018",
        "GL-ES-OSTEO-MEN-2012"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "Breasts enlarged and tender after a year of estrogen injections he was made to accept; finds it humiliating and has stopped changing in front of other runners",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic patient-centered concern echoing the documented effect of his hormone treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "Low mood, poor sleep, low libido, and loss of interest since the prosecution and the hormone course; wants to know whether his body will return to normal, and wants no treatment he has not agreed to",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "Testosterone, LH, and FSH back in the reference range within six months of the last estrogen dose, without testosterone therapy",
        "status": "completed",
        "target_date": "2026-08-04",
        "outcome": "Testosterone 452 ng/dL with normal LH and FSH at sixteen weeks",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic recovery goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "Breast tenderness gone and gynecomastia reduced; a surgical opinion offered if it persists and troubles him",
        "status": "active",
        "target_date": "2026-10-06",
        "outcome": "Tenderness gone by six months; small residual glandular tissue; watchful waiting to twelve months",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic gynecomastia goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "Depression response (PHQ-9 down by at least 50 percent) by sixteen weeks, then remission (PHQ-9 below 5)",
        "status": "completed",
        "target_date": "2026-10-06",
        "outcome": "PHQ-9 7 at sixteen weeks (down 53 percent) and 4 at six months",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic measurement-based care goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "Back to running about 40 km a week and changing at his club again",
        "status": "completed",
        "target_date": "2026-10-06",
        "outcome": "Running 40 km a week and back with the club by six months",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic activity goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Consent first: every examination, test, and treatment is explained and offered, and he may decline any of it; intimate examinations only with his agreement at each step and with a chaperone offered. The estrogen he was given as a condition of avoiding prison was not freely consented treatment, and no further doses will be given",
        "status": "completed",
        "guideline_ids": [
          "GL-APA-SM-2021",
          "GL-EAA-GM-2019",
          "GL-ES-HYPOGONAD-2018"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004",
            "CLM-0005",
            "CLM-0012",
            "CLM-0013"
          ],
          "synthetic_reason": "Synthetic consent and trauma-informed care plan; the documented coercion is the reason for it.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Gynecomastia workup: breast and testicular examination; testosterone, estradiol, LH, FSH, prolactin, SHBG, hCG, AFP, liver, kidney, and thyroid tests today; scrotal ultrasound; breast ultrasound only if the examination becomes equivocal",
        "status": "completed",
        "guideline_ids": [
          "GL-EAA-GM-2019",
          "GL-ES-HYPOGONAD-2018"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic workup following the EAA 2019 guideline, which advises a full evaluation even when a drug cause is apparent.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Endocrinology consultation to confirm that the estrogen explains the findings and to advise on recovery of the gonadal axis, testosterone therapy, bone health, and surgery",
        "status": "completed",
        "guideline_ids": [
          "GL-EAA-GM-2019",
          "GL-ES-HYPOGONAD-2018"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic specialist consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "INT-004",
        "display": "Watchful waiting for the gynecomastia after the estrogen stops; testosterone, estradiol, LH, and FSH every six to eight weeks until normal; no testosterone therapy while the axis is recovering; a surgical opinion if gynecomastia persists about twelve months and troubles him",
        "status": "completed",
        "guideline_ids": [
          "GL-EAA-GM-2019",
          "GL-ES-HYPOGONAD-2018"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic monitoring plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "INT-005",
        "display": "Bone health: vitamin D replacement, calcium from food, continued running and strength work; bone density scan only if hypogonadism persists beyond six months or a fracture occurs",
        "status": "completed",
        "guideline_ids": [
          "GL-EAA-GM-2019",
          "GL-ES-HYPOGONAD-2018",
          "GL-ES-OSTEO-MEN-2012"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic bone-health plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "INT-006",
        "display": "Weekly psychotherapy with a gay-affirming clinic psychologist for about 16 sessions, addressing the prosecution, the coerced treatment, and minority stress; an antidepressant offered and declined for now, to be reconsidered if the PHQ-9 has not fallen by half at about eight weeks",
        "status": "completed",
        "guideline_ids": [
          "GL-MDD-2022",
          "GL-CMID-2026",
          "GL-APA-SM-2021"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic shared decision: psychotherapy alone is an option for a moderate first episode, and he did not want another medicine at intake.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "INT-007",
        "display": "Collaborative safety plan with warning signs, coping steps, people to contact, the clinic number, and the 988 Suicide & Crisis Lifeline; suicide-risk review and PHQ-9 at every visit",
        "status": "completed",
        "guideline_ids": [
          "GL-SUICIDE-2024",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic safety planning; no current ideation is asserted.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "INT-008",
        "display": "Sexual health as routine adult care: HIV and STI testing and a PrEP discussion offered at his preventive visit, with his consent; libido and erectile function reviewed as testosterone recovers",
        "status": "completed",
        "guideline_ids": [
          "GL-CDC-STI-2021",
          "GL-USPSTF-PREP-2023",
          "GL-APA-SM-2021"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic routine sexual health plan; nothing about his orientation is treated as a problem.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "INT-009",
        "display": "Affirming practice: his orientation, name, and pronouns recorded as he chooses; his records shared only with his consent; a written letter from this clinic, at his request, confirming that the estrogen he was given was not medically indicated",
        "status": "completed",
        "guideline_ids": [
          "GL-APA-SM-2021"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic LGBTQ-affirming care plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T10:00:00-05:00"
        }
      },
      {
        "id": "INT-010",
        "display": "Add bupropion XL 150 mg each morning, chosen by him after an informed discussion of options and side effects; nurse telephone check at two weeks; PHQ-9 and blood pressure at each visit",
        "status": "completed",
        "guideline_ids": [
          "GL-CMID-2026",
          "GL-MDD-2022"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic medication decision at the eight-week visit for a partial response to psychotherapy alone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T11:30:00-05:00"
        },
        "recorded_date": "2026-06-09"
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-EAA-GM-2019",
        "title": "EAA clinical practice guidelines: gynecomastia evaluation and management",
        "publisher": "European Academy of Andrology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/31099174/",
        "version_or_year": "2019"
      },
      {
        "guideline_id": "GL-ES-HYPOGONAD-2018",
        "title": "Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline",
        "publisher": "Endocrine Society",
        "url": "https://pubmed.ncbi.nlm.nih.gov/29562364/",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-ES-OSTEO-MEN-2012",
        "title": "Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline",
        "publisher": "Endocrine Society",
        "url": "https://pubmed.ncbi.nlm.nih.gov/22675062/",
        "version_or_year": "2012"
      },
      {
        "guideline_id": "GL-MDD-2022",
        "title": "VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder",
        "publisher": "United States Department of Veterans Affairs and Department of Defense",
        "url": "https://www.healthquality.va.gov/guidelines/MH/mdd/",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-SUICIDE-2024",
        "title": "VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide",
        "publisher": "United States Department of Veterans Affairs and Department of Defense",
        "url": "https://healthquality.va.gov/HEALTHQUALITY/guidelines/mh/srb/index.asp",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-CMID-2026",
        "title": "CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/topthirty/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-APA-SM-2021",
        "title": "APA Guidelines for Psychological Practice With Sexual Minority Persons",
        "publisher": "American Psychological Association",
        "url": "https://pubmed.ncbi.nlm.nih.gov/35143229/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-CDC-STI-2021",
        "title": "Sexually Transmitted Infections Treatment Guidelines: Men Who Have Sex with Men",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/std/treatment-guidelines/msm.htm",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-PREP-2023",
        "title": "Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-AB",
        "title": "USPSTF A and B Recommendations",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-STATIN-2022",
        "title": "Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/statin-use-in-adults-preventive-medication",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-USPSTF-HIV-2019",
        "title": "Human Immunodeficiency Virus (HIV) Infection: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening",
        "version_or_year": "2019"
      },
      {
        "guideline_id": "GL-USPSTF-HCV-2020",
        "title": "Hepatitis C Virus Infection in Adolescents and Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-USPSTF-SYPH-2022",
        "title": "Syphilis Infection in Nonpregnant Adolescents and Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/syphilis-infection-nonpregnant-adults-adolescents-screening",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-USPSTF-ALC-2018",
        "title": "Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/unhealthy-alcohol-use-in-adolescents-and-adults-screening-and-behavioral-counseling-interventions",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-DEP-2023",
        "title": "Depression and Suicide Risk in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-USPSTF-CRC-2021",
        "title": "Colorectal Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-CDC-IMZ-2026",
        "title": "Adult Immunization Schedule by Age",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-OTTAWA-1992",
        "title": "A study to develop clinical decision rules for the use of radiography in acute ankle injuries",
        "publisher": "Annals of Emergency Medicine",
        "url": "https://pubmed.ncbi.nlm.nih.gov/1554175/",
        "version_or_year": "1992"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review; check the gynecomastia workup and watchful waiting, recovery of the gonadal axis without testosterone therapy, the bone-health plan, the depression treatment and safety review at every visit, routine sexual health care, and the recorded deviation."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "Hodges's biography pages, MacTutor, a BBC report, a GOV.UK press release, and a University of Manchester news item logged. The prosecution, the hormone treatment, Jungian analysis, and the death and verdict are D; depression and both readings of his death are R. The tablet-and-implant account of the treatment was not verified."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "Safety assessment is synthetic with no current ideation; the disputed circumstances of his death are recorded only as history, in plain terms and without method detail, and are not echoed in the modern episode. Sexual orientation is recorded respectfully and never as a problem."
    }
  }
}
